Canada Markets open in 6 hrs 9 mins

AbbVie Is Buying Allergan. Wall Street Has Doubts.

Josh Nathan-Kazis

The biopharmaceutical company AbbVie plans to acquire Allergan, the maker of Botox, for approximately $63 billion in cash and stock.